TRIPTODUR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triptodur, and when can generic versions of Triptodur launch?
Triptodur is a drug marketed by Azurity and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in TRIPTODUR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
DrugPatentWatch® Generic Entry Outlook for Triptodur
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIPTODUR?
- What are the global sales for TRIPTODUR?
- What is Average Wholesale Price for TRIPTODUR?
Summary for TRIPTODUR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for TRIPTODUR |
| What excipients (inactive ingredients) are in TRIPTODUR? | TRIPTODUR excipients list |
| DailyMed Link: | TRIPTODUR at DailyMed |
US Patents and Regulatory Information for TRIPTODUR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | 10,166,181 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
